Publications

Preclinical, ZW1528
World Bispecific & T Cell Engager Summit
June 11, 2026
ZW1528, a Bispecific Antibody Targeting IL-4Ra and IL-33 Potently Inhibits Key Mediators of Airway Inflammation
Hardman et al.
Clinical, ZW191
ESMO Gynaecological Cancers Congress
June 15, 2026
Efficacy analysis of ZW191 by folate receptor α (FRα) expression level in a phase 1 study
Hasegawa et al.
Clinical, Zanidatamab
The New England Journal of Medicine
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer
Shitara et al.
Preclinical, ZW1528
Respiratory Innovation Summit
May 15 - May 16, 2026
ZW1528: IL-4Rα x IL-33 Bispecific Antibody for Treatment of COPD
Hardman et al.
Preclinical
PEGS
May 14, 2026
TriTCE Co-Stim: A Differentiated T Cell Engager Platform With Conditional Cis CD28 Co-Stimulation
Genevieve Desjardins, PhD
Preclinical
PEGS
May 12, 2026
Uniting Discovery Strategy and Engineering for the Best-in-Class Antibodies for ADCs
Righetto et al.
Clinical, ZW191
AACR
April 21, 2026
Phase 1 first-in-human multicenter open-label study of ZW191, a folate receptor α (FRα)–targeting antibody-drug conjugate (ADC), in patients with advanced solid tumors: Part 1 dose-escalation results
LoRusso et al.
Preclinical
AACR
April 21, 2026
Unlocking novel biologies with bi- and trispecific antibodies: The importance of antibody format
Nina Weisser, PhD
Preclinical
AACR
April 17, 2026
ZW439, a novel CLDN18.2-targeting pan-RAS inhibitor antibody drug conjugate for the treatment of RAS mutated pancreatic cancer
Lawn et al.
Preclinical
AACR
April 17, 2026
A pan-RASi antibody-drug conjugate platform with high activity in RAS-mutant cancers
Garnett et al.
Preclinical
AACR
April 17, 2026
ZW427, a Ly6E-targeting antibody drug conjugate bearing a novel pan-RAS inhibitor payload for the treatment of RAS mutated cancers
Urosev et al.
Preclinical
AACR
April 17, 2026
Development of ZW418, a biparatopic PTK7-targeting antibody-drug conjugate incorporating a novel pan-RAS inhibitor payload for the treatment of non-small cell lung cancer
Fung et al.